Charles River Laboratories International, Inc.
Location
Massachusetts
Founded
1947-02-28
Website
Risk Signals
1064 news mentions monitored
Industry Context
This company is tracked across risk categories, including those related to its sector (e.g., Commercial Physical and Biological Research, Testing Laboratories), including supply chain integrity, ESG practices, labor disputes, and regulatory compliance.
Filter risk signals by topic
Select a theme below to explore the company’s news mentions in specific risk areas.
Recent Articles about Charles River Laboratories International, Inc.
Live alerts from global media, monitored by Business Radar
2025-04-14 (inkl.com)
Stock Market Today: Dow Jones Up As Fed's Waller Says This On Rate Cuts; Trump Wants To 'Help' Autos But Tesla Lags (Live Coverage)
The Dow Jones rose on the stock market today and auto stocks popped after President Donald Trump spoke out. Palantir stock was higher while Nvidia…
Read more
2025-02-22 (defenseworld.net)
JPMorgan Chase & Co. Has Lowered Expectations for Charles River Laboratories International (NYSE:CRL) Stock Price -
Read JPMorgan Chase & Co. Has Lowered Expectations for Charles River Laboratories International (NYSE:CRL) Stock Price at Defense World
Read more
2025-02-18 (defenseworld.net)
V Square Quantitative Management LLC Purchases 121 Shares of Charles River Laboratories International, Inc. (NYSE:CRL) -
Read V Square Quantitative Management LLC Purchases 121 Shares of Charles River Laboratories International, Inc. (NYSE:CRL) at Defense World
Read more
2025-01-26 (pando.life)
Maisoplasma Platinum Market size / Prediction 2025 《Pando》
Posted by sdonald04328. The “mycoplasma plate antigen market” prioritizes cost control and efficiency gains. Additionally, the report covers both the demand and supply sides of the market. The mycoplasma plate antigen market is expected to grow at an annual rate of 5% from 2025 to 2032. The entire report is 149 pages. My co-op...
Read more![Cell Therapy Market Report [2031] – Size, Share, Growth](https://images.businessradar.com/articles/6f706a26-d7a5-48f2-9a3d-88c508c13135)
2025-01-25 (kingsresearch.com)
Cell Therapy Market Report [2031] – Size, Share, Growth
The scale of the cell therapy market is expected to increase from US $ 10.84 billion in 2024 to US $ 26.59 billion in 2031, with a compound annual growth rate of 13.67%.
Read more
2025-01-23 (openpr.com)
Cell Bank Creation Service Market Overall Study Report 2025-2032 | BioReliance by Merck, Charles River Laboratories International, Inc., Corning Incorporated
Press release - Coherent Market Insights - Cell Bank Creation Service Market Overall Study Report 2025-2032 | BioReliance by Merck, Charles River Laboratories International, Inc., Corning Incorporated - published on openPR.com
Read more
2025-01-23 (investing.com)
William Blair downgrades Charles River Labs stock to Market Performance Provided by Investing.com
William Blair analysts downgraded shares of Charles River Laboratories International Inc. (NYSE: CRL) from "outperform" to "market perform" on Wednesday. The decision comes amid growing concerns about the company's near-term prospects, with the stock currently trading near its 52-week low of $160.84.
Read more
2025-01-20 (marketbeat.com)
William Blair Has Negative Forecast for CRL FY2025 Earnings
Charles River Laboratories International, Inc. (NYSE:CRL - Free Report) - Stock analysts at William Blair dropped their FY2025 earnings per share estimates for shares of Charles River Laboratories International in a research report issued to clients and investors on Wednesday, January 15th. Willi
Read more
2025-01-17 (trefis.com)
Why Charles River Laboratories International Stock Moved: CRL Stock Has Lost 54% Since 2021 Fiscal End, Primarily Due To Unfavorable Change In Price To Sales Multiple (P/S) |
Why Charles River Laboratories International (CRL) stock moved since 2021
Read more